|Alex Chang ZOU|
School of Biomedical Sciences
The Chinese University of Hong Kong
Alex Chang ZOU, is a qualified physician and treated both emergency and in-hospital patients with surgical disorders as in Dong Rui Hospital, Nanjing, China. He is presently working as Deputy Director in Clinical Research Centre. His previous research work includes:
1. Selection and validation of esophageal cancer cell targeting phage-displayed peptides.
2. Dose-effect curve study and new applications development of human recombinant endostatin.
3. Preclinical study of an anti-VEGF monoclonal antibody drug. Functional study of estrogen-related receptor alpha in prostate cancer.
4. Estrogen-related receptor alpha in Castration-Resistance Prostate Cancer.
He also provided an original idea and prepared preliminary data for the grant applying and found that ERRï¡ overexpression in prostate cancer contribute to its Bicalutamide-resistance and androgen independent growth both in vitro and in vivo.
Molecular cloning techniques; protein-protein interaction analysis: Co-IP, FRET, phage-displayed peptide library screening and identification (in vivo and in vitro); tumor angiogenesis analysis (in vitro and in vivo); histology techniques (slices and IHC); tissue culturing; construction and identification of sub-cell line by both transfection and infection; polyclonal antibody production in rabbit and purification, animal handling: tumor xenograft model constructing in mice subcutaneously and orthotopic, drug administration in mice by garage, i.p. and i.v. by tail vein.
Global Speakers in the subject
Global Experts in the subject
türk porno izletürk pornoları doyasıya izleyin ve boşalın.